N@N

Celera Corporation Fourth Quarter Calendar 2008 Results and Conference Call Scheduled for February 17, 2009

_{//science-technology.news-articles.net/content/2 .. ference-call-scheduled-for-february-17-2009.html}
^{Published in Science and Technology on Thursday, January 22nd 2009 at 13:49 GMT, Last Modified on 2009-01-22 13:50:30 by Market Wire}  

ALAMEDA, Calif.--([ BUSINESS WIRE ])--Celera Corporation (NASDAQ:CRA) announced today that it will issue fourth quarter calendar 2008 financial results on Tuesday, February 17, 2009. Results are scheduled for release after the close of trading on the NASDAQ stock market. Kathy Ordoñez, Chief Executive Officer, and Joel Jung, Chief Financial Officer, will lead a conference call the same day at 4:30 p.m. (ET) to discuss these results and other matters related to the business.

The management team will make prepared remarks and answer questions from securities analysts and investment professionals. Investors, securities analysts, representatives of the media and other interested parties who would like to participate should dial (866) 543-6408, or (617) 213-8899 for international callers, and enter passcode 34414357 at any time from 4:15 p.m. (ET) until the end of the call. This conference call will also be webcast. Interested parties who wish to listen to the webcast should visit the "Media and Investors" section on [ www.celera.com ]. A digital recording will be available approximately two hours after the completion of the conference call on February 17 until March 3, 2009. Interested parties should call (888) 286-8010, or (617) 801-6888 for international callers, and enter passcode 78314114.

About Celera

Celera is a healthcare business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and improve patient management. Celera also commercializes a wide range of molecular diagnostic products through Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer and liver diseases. Information about Celera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at [ http://www.celera.com ].

Copyright© 2009. Celera Corporation. All Rights Reserved. Celera is a registered trademark of Celera Corporation or its subsidiaries in the U. S. and/or certain other countries.